Dr. J. Koenderink
The Alternating Hemiplegia of Childhood Foundation is pleased to announce a partnership with the AHC Association of Iceland to fund a grant to the Radboud University Nijmegen Medical Center, the Netherlands.With both organizations each contributing half of the funding, Dr. J Koenderink, as the primary investigator, will receive a grant in the amount of $26,518.00, or the equivalent of €20,000.00.
AHC is a rare disease (1:1,000,000) that is caused by a mutation in the ATP1A3 gene found in approximately 75% of all AHC patients. AHC causes temporary paralysis on one or both sides of the body and characteristically alternates. It is often accompanied by dystonia, nystagmus, developmental delays, and 50% of AHC patients also have epilepsy.
Currently, more than 20 different AHC mutations of the ATP1A3 gene have been reported.
At this moment it is very important to fully understand the molecular consequences of all these mutations. This research will attempt to explore and understand the direct relation between these mutations and AHC.
We are pleased to participate in this important research project getting us ever closer to a treatment and a cure! Thank You to all the families who fundraise to make this possible.